CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 22 No. 13
INTEGRATIVE ONCOLOGY: COMPLEMENTARY THERAPIES, HERBS, AND OTHER OTC AGENTS 

Coriolus versicolor

By Barrie Cassileth, PhD

| November 1, 2008
Integrative Oncology is the synthesis of mainstream care and nonpharmacologic, evidence-based complementary therapies for the control of cancer-related physical and emotional symptoms. Herb-drug interactions and other cautions are also encompassed. This month, in the first of two installments about medicinal mushrooms, we review Coriolus versicolor, which is widely used in cancer therapies in Asia. In the November 30 issue of ONCOLOGY, this column will address the use of a second type of medicinal mushroom called maitake.

PolysaccharideK (PSK), a protein-bound polysaccharide isolated from Coriolus versicolor, is widely used in Asia as an adjuvant agent in the treatment of cancer. Research into the biologic mechanisms underlying the anticancer effects of PSK is ongoing, but PSK appears promising. More than 2 dozen human studies of PSK have been reviewed by experts at the University of Texas M.D. Anderson Cancer Center. Almost all of these studies were done in Japan and focused on cancers of the esophagus, stomach, colon, or breast. Most of them found that people with cancer were helped by PSK. People who received PSK along with other treatments, such as surgery, chemotherapy, or radiation therapy, generally had longer disease-free periods and increased survival rates compared with patients who got only standard treatment. Side effects from PSK in these studies were very mild. Smaller studies have suggested PSK may not be as effective against liver cancer or leukemia. Adverse effects are rare with use of medicinal mushrooms. However, because over-the-counter Coriolus products are not standardized, and because medicinal mushrooms may interfere with immunosuppressant medications, patients should use caution and consult their physicians before taking medicinal mushroom supplements.

SCIENTIFIC NAMES: Coriolus versicolor, Trametes versicolor, Polyporus versicolor, Polystictus Figureversicolor

ALSO KNOWN AS: PSK, PSP, VPS, turkey tail, yun zhi, kawaratake, Krestin

BACKGROUND: Coriolus versicolor is a mushroom of the Basidiomycetes class. These are fungi with gills or pores, the group that includes the familiar edible mushrooms. Coriolus is used not as food, but as medicine ingested as capsules, as an extract, or as a tea. It was applied initially in traditional Chinese medicine as a tonic, but recent studies indicate immunostimulant and antitumor properties for which its proteoglycan constituents are responsible.

RESEARCH: Polysaccharide K (PSK), a proprietary product derived from Coriolus, was developed for cancer treatment in Japan. When used as an adjuvant agent, PSK enhanced immune response in vivo[1] and improved survival rates in patients with gastric[2] and colorectal cancers.[3]

Other Coriolus extracts, such as polysaccharide peptide (PSP) and versicolor polysaccharide (VPS), are available as dietary supplements. Preliminary studies show that these extracts reduce chemotherapy toxicity, increase effectiveness of chemotherapy or radiotherapy, and have antiproliferative and cytotoxic activities.[4] When used with chemotherapy, PSP may benefit patients with advanced non–small-cell lung cancer.[5]

Clinical investigations using Coriolus extract alone or in combination with other botanicals also suggest positive immunomodulatory effects.[6,7]

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.





REFERENCES
1. Raghupati G, Yeung KS, Leung PC, et al: Evaluation of widely consumed botanicals as immunological adjuvants. Vaccine 26:4860-4865, 2008.
2. Oba K, Teramukai S, Kobayashi M, et al: Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer. Cancer Immunol Immunother 56:905-911, 2007.
3. Sakamoto J, Morita S, Oba K, et al: Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: A meta-analysis of centrally randomized controlled clinical trials. Cancer Immunol Immunother 55:404-411, 2006.
4. Lau CB, Ho CY, Kim CF, et al: Cytotoxic activities of Coriolus versicolor (Yunzhi) extract on human leukemia and lymphoma cells by induction of apoptosis. Life Sci 75:797-808, 2004.
5. Tsang KW, Lam CL, Yan C, et al: Coriolus versicolor polysaccharide peptide slows progression of advanced non-small cell lung cancer. Respir Med 97:618-624, 2003.
6. Wong CK, Tse PS, Wong EL, et al: Immunomodulatory effects of yun zhi and danshen capsules in health subjects—a randomized, double-blind, placebo-controlled, crossover study. Int Immunopharmacol 4:201-211, 2004.
7. Wong CK, Bao YX, Wong EL, et al: Immunomodulatory activities of Yunzhi and Danshen in post-treatment breast cancer patients. Am J Chin Med 33:381-395, 2005.
For additional information visit the Memorial Sloan-Kettering Cancer Center Integrative Medicine Service free website, “About Herbs” at http://www.mskcc.org/AboutHerbs.


 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

A 52-Year-Old Man Presents With an Erythematous Lesion
Cesar Moran, MD , May 22, 2013

A 52-year-old man presented with an erythematous lesion in the axilla of unknown duration. Surgical excision was performed. What is your diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Colorectal Cancer Treatments and Therapy Innovations
  • A 52-Year-Old Man Presents With an Erythematous Lesion
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Preventing Exposure to Hazardous Drugs
  • Conflicts of Interest in Medicine: What About Ties to Payers?
  • Planning Treatment for Women With Recurrent Epithelial Ovarian Cancer
  • Rising PSA Level in a 46-Year-Old Man
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy